Federal agents are executing warrants at Twin Cities daycare providers

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Last month the Food and Drug Administration announced that it would 

remove its warning on hormone-based products

As women age, most will experience changes linked to the stop of their monthly menses, including hot flashes, bone density loss and sleep problems. But in the past two decades a strong “black-box warning” has scared many women off from seeking relief in hormone creams, patches, pills and other treatments. 

The warning was added following a landmark study that linked hormone therapy to an increased risk for cancer and cardiovascular problems. Now the FDA says the risks were overblown for most women. 

MPR News guest host Catharine Richert talks about the FDA’s change, the risks and benefits of hormone therapy and what women should consider as they decide whether to try it. 

Subscribe to the MPR News with Angela Davis podcast on:

Use the audio player above to listen to the full conversation.

Health

Shows

MPR News with Angela Davis

On Air

Host

Author

MPR News guest host Catharine Richert talks about the FDA’s decision to remove warnings on hormone therapies to treat menopause symptoms. 

MPR News with Angela Davis - MPR News guest host Catharine Richert talks with Dr. Jissy Cyriac from Mayo Clinic about the FDA’s decision to remove warnings on hormone therapies to treat menopause symptoms.

New thinking on menopause and hormone therapy

Go Deeper.

Like this?

News you can use in your inbox